Viveve Solutions
Viveve provides women low risk, high reward medical procedures that promote personal health and wellness. The company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide. The internationally patented Viveve System incorporates Cryogen-cooled Monopolar Radiofrequency (CMRF) technology to uniformly provide an endovaginal treatment that is non-ablative. The Viveve System is currently used by physicians and women’s healthcare practitioners in the U.S. and Asian Pacific Countries. In the United States, the Viveve System is approved for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances include its use for vaginal laxity and/or improvement of sexual function and/or improvement of Stress Urinary Incontinence in women.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
Our mission is to enhance women’s lives by providing clinically proven, non-invasive products to improve female
Stress Urinary Incontinence
PURSUIT is a randomized, double-blinded, sham-controlled, IDE-cleared trial that enrolled 415 subjects with moderate SUI at approximately 30 study sites in the United States. Subjects were randomized in a 2:1 ratio to the active Viveve treatment or an inert sham treatment.
The internationally patented Viveve® System incorporates Cryogen-cooled Monopolar Radiofrequency (CMRF) technology to uniformly provide an endovaginal treatment that is non-ablative.
Clinical EvidenceConducting clinical trials to prove safety and efficacy of our technology is foundational to Viveve. Large, multicenter, randomized, and blinded clinical trials conducted following U.S. and International regulatory agency requirements is Viveve’s tradition. Sound clinical studies provide evidence that demonstrates the effectiveness of a medical device to safely treat a specific medical condition.
Internationally PatentedViveve has a strong, protected intellectual property portfolio of U.S. and International patents for its Cryogen-cooled Monopolar Radiofrequency (CMRF) dual energy technology platform and its use in vaginal tissue. Recently, a new U.S. Method Patent for Stress Urinary Incontinence was issued to further strengthen the Company’s IP portfolio.